Obsessive-compulsive disorder: a double-blind, placebo-controlled trial of clomipramine in 27 patients



	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted



	Email this article to a Colleague
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Add to My Articles & Searches
	Download to citation manager



	Citing Articles via HighWire
	Citing Articles via Google Scholar



	Articles by Jenike, M. A.
	Articles by Seymour, R.
	Search for Related Content



	PubMed Citation
	Articles by Jenike, M. A.
	Articles by Seymour, R.

Am J Psychiatry 1989; 146:1328-1330
Copyright © 1989 by American Psychiatric Association

REGULAR ARTICLES

Obsessive-compulsive disorder: a double-blind, placebo-controlled trial of clomipramine in 27 patients

MA Jenike, L Baer, P Summergrad, JB Weilburg, A Holland and R Seymour
Harvard Medical School and Massachusetts General Hospital, Boston 02114.

Clomipramine was significantly superior to placebo in a 10-week double- blind, placebo-controlled trial in 27 outpatients who met DSM-III-R criteria for obsessive-compulsive disorder.

This article has been cited by other articles:

R. Michels and P. M. Marzuk
Progress in Psychiatry- Second of Two Parts
N. Engl. J. Med., August 26, 1993; 329(9): 628 - 638.
[Full Text]

Get information about faster international access.